Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
4.290
+0.170 (4.13%)
At close: Feb 27, 2026, 4:00 PM EST
4.250
-0.040 (-0.93%)
After-hours: Feb 27, 2026, 7:56 PM EST
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $66.38 million as of February 27, 2026. Its market cap has increased by 88.59% in one year.
Market Cap
66.38M
Enterprise Value
47.71M
1-Year Change
88.59%
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $66.38M, a decrease of -99.03%. That is a compound annual growth rate of -34.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 66.40M | 35.79% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 67.62M |
| Q32 Bio | 66.50M |
| InflaRx | 63.09M |
| TScan Therapeutics | 62.99M |
| Spruce Biosciences | 62.67M |
| NRx Pharmaceuticals | 61.51M |
| Mereo BioPharma Group | 61.42M |
| Instil Bio | 60.97M |